Telangana HPV Vaccination Drive Reaches 91,289; Government Extends Campaign Deadline to August
The HPV vaccination campaign in Telangana has reached 91,289 girls. Due to heat, exams, and logistical challenges, the Union government has extended the program deadline to August, aiming to improve coverage and address the significant public health risk of cervical cancer.

Highlights
- •The HPV vaccination drive in Telangana has reached 91,289 beneficiaries.
- •The Union government extended the campaign deadline by three months to August.
- •Approximately 2.85 lakh eligible girls in the state remain currently unvaccinated.
- •Cervical cancer is the second most common cancer in Indian women, causing 80,000 annual deaths.
The state-wide HPV vaccination drive in Telangana has successfully reached 91,289 beneficiaries as of June 17, marking a steady, albeit challenging, progression in the immunization campaign aimed at 14-year-old girls. While this initiative represents a significant step forward in public health, approximately 2.85 lakh eligible girls across the state remain without the vaccine, indicating that substantial efforts are still required to achieve broad coverage.
Extending the HPV Vaccination Drive Timeline
Originally slated to finish by June 8, the HPV vaccination drive has received an extension from the Union government, pushing the completion deadline to August. Health officials have identified several factors contributing to the need for this extension, including extreme summer heat, academic examination schedules, and the commitment of state resources to other vital health programs. By providing an additional three months, the government aims to overcome these logistical barriers and maximize outreach to the target demographic.
Data indicates that Telangana is currently ranked approximately 15th among India’s 36 states and Union Territories, having achieved a 28.4 per cent coverage rate. While the state has vaccinated 80,951 girls against its 2.85 lakh target, local officials maintain that the most recent figure of 91,289 beneficiaries has not yet been processed into the national database. In contrast, states such as Gujarat and Madhya Pradesh have already surpassed their initial targets, reporting coverage rates exceeding 100 per cent.
Addressing Public Health Concerns and Future Strategies
The urgency behind the HPV vaccination drive is underscored by the severe health risks associated with human papillomavirus. Research suggests that this vaccine is critical in reducing the risk of cervical cancer—a major public health issue in India—to effectively zero for individuals vaccinated before the age of 30. According to WHO Globoscan data from 2022, cervical cancer stands as the second most prevalent cancer among women in India, resulting in over 1,20,000 new diagnoses and approximately 80,000 fatalities annually.
To improve participation, health authorities are intensifying mobilization strategies, particularly within government-run academic institutions. Teachers have been tasked with encouraging eligible students to visit designated immunization sites, including primary health centers, area hospitals, and community medical facilities. With the deadline extended, the government remains optimistic that these coordinated actions will significantly bolster the state's total coverage, bringing Telangana closer to its national health goals and ensuring better protection for young women against cervical cancer.






